Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering

Due to the vague symptomatology of the disease and a lack of effective screening methods, most patients with epithelial ovarian cancer (EOC) present late in their disease. Despite advances in chemotherapeutic agents, the prognosis of these patients has uniformly been extremely poor. Although cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Poplawska, Maria, Dutta, Dibyendu, Lee, Yichun, Lim, Seah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604669/
https://www.ncbi.nlm.nih.gov/pubmed/34853809
http://dx.doi.org/10.1016/j.omto.2021.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604669/
https://www.ncbi.nlm.nih.gov/pubmed/34853809
http://dx.doi.org/10.1016/j.omto.2021.10.010

Ejemplares similares